R4 Draft for Comment
TerminologyThis page is part of the FHIR Specification (v3.2.0: R4 Ballot 1). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions 
. Page versions: R4 R3 R2
| Vocabulary Work Group | Maturity Level: N/A | Ballot Status: Informative |
OpenIssue: Missing description.
<ValueSet xmlns="http://hl7.org/fhir"> <id value="v3-EntityCode"/> <meta> <lastUpdated value="2017-07-31T00:00:00.000+10:00"/> <profile value="http://hl7.org/fhir/StructureDefinition/shareablevalueset"/> </meta> <text> <status value="generated"/> <div xmlns="http://www.w3.org/1999/xhtml"> <p> Release Date: 2017-07-31</p> <table class="grid"> <tr> <td> <b> Level</b> </td> <td> <b> Code</b> </td> <td> <b> Display</b> </td> <td> <b> Definition</b> </td> </tr> <tr> <td> 1</td> <td> <span style="color: grey"> <i> (_MaterialEntityClassType)</i> </span> <b> <i> Abstract</i> </b> </td> <td> <a name="v3-EntityCode-_MaterialEntityClassType"> </a> </td> <td> Types of Material for EntityClass "MAT" <br/> </td> </tr> <tr> <td> 2</td> <td> <span style="color: grey"> <i> (_ContainerEntityType)</i> </span> <b> <i> Abstract</i> </b> </td> <td> <a name="v3-EntityCode-_ContainerEntityType"> </a> </td> <td> Material intended to hold another material for purpose of storage or transport. <br/> </td> </tr> <tr> <td> 3</td> <td> PKG <a name="v3-EntityCode-PKG"> </a> </td> <td> Package</td> <td> A material intended to hold other materials for purposes of storage or transportation <br/> </td> </tr> <tr> <td> 4</td> <td> <span style="color: grey"> <i> (_NonRigidContainerEntityType)</i> </span> <b> <i> Abstract</i> </b> </td> <td> <a name="v3-EntityCode-_NonRigidContainerEntityType"> </a> </td> <td> A container having dimensions that adjust somewhat based on the amount and shape of the material placed within it. <br/> </td> </tr> <tr> <td> 5</td> <td> BAG <a name="v3-EntityCode-BAG"> </a> </td> <td> Bag</td> <td> A pouched or pendulous container. <br/> </td> </tr> <tr> <td> 5</td> <td> PACKT <a name="v3-EntityCode-PACKT"> </a> </td> <td> Packet</td> <td> A paper <br/> </td> </tr> <tr> <td> 5</td> <td> PCH <a name="v3-EntityCode-PCH"> </a> </td> <td> Pouch</td> <td> A small bag or container made of a soft material. <br/> </td> </tr> <tr> <td> 5</td> <td> SACH <a name="v3-EntityCode-SACH"> </a> </td> <td> Sachet</td> <td> A small bag or packet containing a small portion of a substance. <br/> </td> </tr> <tr> <td> 4</td> <td> <span style="color: grey"> <i> (_RigidContainerEntityType)</i> </span> <b> <i> Abstract</i> </b> </td> <td> <a name="v3-EntityCode-_RigidContainerEntityType"> </a> </td> <td> A container having a fixed and inflexible dimensions and volume <br/> </td> </tr> <tr> <td> 5</td> <td> <span style="color: grey"> <i> (_IndividualPackageEntityType)</i> </span> <b> <i> Abstract</i> </b> </td> <td> <a name="v3-EntityCode-_IndividualPackageEntityType"> </a> </td> <td> Container intended to contain sufficient material for only one use. <br/> </td> </tr> <tr> <td> 6</td> <td> AMP <a name="v3-EntityCode-AMP"> </a> </td> <td> Ampule</td> <td> A small sealed glass container that holds a measured amount of a medicinal substance. <br/> </td> </tr> <tr> <td> 6</td> <td> MINIM <a name="v3-EntityCode-MINIM"> </a> </td> <td> Minim</td> <td> Individually dosed ophthalmic solution. One time eye dropper dispenser. <br/> </td> </tr> <tr> <td> 6</td> <td> NEBAMP <a name="v3-EntityCode-NEBAMP"> </a> </td> <td> Nebuamp</td> <td> Individually dosed inhalation solution. <br/> </td> </tr> <tr> <td> 6</td> <td> OVUL <a name="v3-EntityCode-OVUL"> </a> </td> <td> Ovule</td> <td> A container either glass or plastic and a narrow neck, for storing liquid. <br/> </td> </tr> <tr> <td> 5</td> <td> <span style="color: grey"> <i> (_MultiUseContainerEntityType)</i> </span> <b> <i> Abstract</i> </b> </td> <td> <a name="v3-EntityCode-_MultiUseContainerEntityType"> </a> </td> <td> A container intended to contain sufficient material for more than one use. (I.e. Material is intended to be removed from the container at more than one discrete time period.) <br/> </td> </tr> <tr> <td> 6</td> <td> BOT <a name="v3-EntityCode-BOT"> </a> </td> <td> Bottle</td> <td> A container, typically rounded, either glass or plastic with a narrow neck and capable of storing liquid. <br/> </td> </tr> <tr> <td> 7</td> <td> BOTA <a name="v3-EntityCode-BOTA"> </a> </td> <td> Amber Bottle</td> <td> A bottle of yellow to brown color. Used to store light-sensitive materials <br/> </td> </tr> <tr> <td> 7</td> <td> BOTD <a name="v3-EntityCode-BOTD"> </a> </td> <td> Dropper Bottle</td> <td> A bottle with a cap designed to release the contained liquid in droplets of a specific size. <br/> </td> </tr> <tr> <td> 7</td> <td> BOTG <a name="v3-EntityCode-BOTG"> </a> </td> <td> Glass Bottle</td> <td> A bottle made of glass <br/> </td> </tr> <tr> <td> 7</td> <td> BOTP <a name="v3-EntityCode-BOTP"> </a> </td> <td> Plastic Bottle</td> <td> A bottle made of plastic <br/> </td> </tr> <tr> <td> 8</td> <td> BOTPLY <a name="v3-EntityCode-BOTPLY"> </a> </td> <td> Polyethylene Bottle</td> <td> A bottle made of polyethylene <br/> </td> </tr> <tr> <td> 6</td> <td> BOX <a name="v3-EntityCode-BOX"> </a> </td> <td> Box</td> <td> A 6-sided container commonly made from paper or cardboard used for solid forms. <br/> </td> </tr> <tr> <td> 6</td> <td> CAN <a name="v3-EntityCode-CAN"> </a> </td> <td> Can</td> <td> A metal container in which a material is hermetically sealed to enable storage over long periods. <br/> </td> </tr> <tr> <td> 6</td> <td> CART <a name="v3-EntityCode-CART"> </a> </td> <td> Cartridge</td> <td> A sealed container of liquid or powder intended to be loaded into a device. <br/> </td> </tr> <tr> <td> 6</td> <td> CNSTR <a name="v3-EntityCode-CNSTR"> </a> </td> <td> Canister</td> <td> A pressurized metal container holding a substance released as a spray or aerosol. <br/> </td> </tr> <tr> <td> 6</td> <td> JAR <a name="v3-EntityCode-JAR"> </a> </td> <td> Jar</td> <td> A container of glass, earthenware, plastic, etc. Top of the container has a diameter of similar size to the diameter of the container as a whole <br/> </td> </tr> <tr> <td> 6</td> <td> JUG <a name="v3-EntityCode-JUG"> </a> </td> <td> Jug</td> <td> A deep vessel for holding liquids, with a handle and often with a spout or lip shape for pouring. <br/> </td> </tr> <tr> <td> 6</td> <td> TIN <a name="v3-EntityCode-TIN"> </a> </td> <td> Tin</td> <td> A lidded container made of thin sheet metal. <br/> </td> </tr> <tr> <td> 6</td> <td> TUB <a name="v3-EntityCode-TUB"> </a> </td> <td> Tub</td> <td> An open flat bottomed round container. <br/> </td> </tr> <tr> <td> 6</td> <td> TUBE <a name="v3-EntityCode-TUBE"> </a> </td> <td> Tube</td> <td> A long hollow rigid or flexible cylinder. Material is extruded by squeezing the container. <br/> </td> </tr> <tr> <td> 6</td> <td> VIAL <a name="v3-EntityCode-VIAL"> </a> </td> <td> Vial</td> <td> A small cylindrical glass for holding liquid medicines. <br/> </td> </tr> <tr> <td> 5</td> <td> BLSTRPK <a name="v3-EntityCode-BLSTRPK"> </a> </td> <td> Blister Pack</td> <td> A bubblepack. Medications sealed individually, separated into doses. <br/> </td> </tr> <tr> <td> 6</td> <td> CARD <a name="v3-EntityCode-CARD"> </a> </td> <td> Card</td> <td> A bubble pack card. Multiple individual/separated doses. <br/> </td> </tr> <tr> <td> 4</td> <td> COMPPKG <a name="v3-EntityCode-COMPPKG"> </a> </td> <td> Compliance Package</td> <td> A container intended to contain sufficient material for more than one use, but grouped or organized to provide individual access to sufficient material for a single use. Often used to ensure that the proper type and amount of material is consumed/expended for each use. <br/> </td> </tr> <tr> <td> 5</td> <td> <a href="#BLSTRPK">BLSTRPK</a> </td> <td/> <td/> </tr> <tr> <td> 5</td> <td> DIALPK <a name="v3-EntityCode-DIALPK"> </a> </td> <td> Dial Pack</td> <td> Rotatable dispenser. Eg. Birth control package. <br/> </td> </tr> <tr> <td> 5</td> <td> DISK <a name="v3-EntityCode-DISK"> </a> </td> <td> Disk</td> <td> Object that is thin, flat, and circular. Doses of medication often contained in bubbles on the disk. <br/> </td> </tr> <tr> <td> 5</td> <td> DOSET <a name="v3-EntityCode-DOSET"> </a> </td> <td> Dosette</td> <td> Special packaging that will help patients take their medications on a regular basis. <br/> </td> </tr> <tr> <td> 5</td> <td> STRIP <a name="v3-EntityCode-STRIP"> </a> </td> <td> Strip</td> <td> A continuous strip of plastic sectioned into individual pouches, each one containing the quantity of 1 or more medications intended to be administered at a specific time <br/> </td> </tr> <tr> <td> 4</td> <td> KIT <a name="v3-EntityCode-KIT"> </a> </td> <td> Kit</td> <td> A container for a diverse collection of products intended to be used together for some purpose (e.g. Medicinal kits often contain a syringe, a needle and the injectable medication). <br/> </td> </tr> <tr> <td> 5</td> <td> SYSTM <a name="v3-EntityCode-SYSTM"> </a> </td> <td> System</td> <td> A kit in which the components are interconnected. <br/> </td> </tr> <tr> <td> 2</td> <td> <span style="color: grey"> <i> (_MedicalDevice)</i> </span> <b> <i> Abstract</i> </b> </td> <td> <a name="v3-EntityCode-_MedicalDevice"> </a> </td> <td> A device with direct or indirect therapeutic purpose. Values for EntityCode when EntityClass = "DEV" <br/> </td> </tr> <tr> <td> 3</td> <td> <span style="color: grey"> <i> (_AccessMedicalDevice)</i> </span> <b> <i> Abstract</i> </b> </td> <td> <a name="v3-EntityCode-_AccessMedicalDevice"> </a> </td> <td> A device used to allow access to a part of a body <br/> </td> </tr> <tr> <td> 4</td> <td> LINE <a name="v3-EntityCode-LINE"> </a> </td> <td> Line</td> <td> A hollow tube used to administer a substance into a vein, artery or body cavity <br/> </td> </tr> <tr> <td> 5</td> <td> IALINE <a name="v3-EntityCode-IALINE"> </a> </td> <td> Intra-arterial Line</td> <td> A line used to administer a substance into an artery <br/> </td> </tr> <tr> <td> 5</td> <td> IVLINE <a name="v3-EntityCode-IVLINE"> </a> </td> <td> Intraveneous Line</td> <td> A line used to administer a substance into a vein <br/> </td> </tr> <tr> <td> 3</td> <td> <span style="color: grey"> <i> (_AdministrationMedicalDevice)</i> </span> <b> <i> Abstract</i> </b> </td> <td> <a name="v3-EntityCode-_AdministrationMedicalDevice"> </a> </td> <td> A device intended to administer a substance to a subject <br/> </td> </tr> <tr> <td> 4</td> <td> <span style="color: grey"> <i> (_InjectionMedicalDevice)</i> </span> <b> <i> Abstract</i> </b> </td> <td> <a name="v3-EntityCode-_InjectionMedicalDevice"> </a> </td> <td> A device intended to administer liquid into a subject via a <br/> </td> </tr> <tr> <td> 5</td> <td> AINJ <a name="v3-EntityCode-AINJ"> </a> </td> <td> AutoInjector</td> <td> Automatically injects medication. <br/> </td> </tr> <tr> <td> 5</td> <td> PEN <a name="v3-EntityCode-PEN"> </a> </td> <td> Pen</td> <td> A device which can contain a cartridge for injection purposes. Eg. Insulin pen. <br/> </td> </tr> <tr> <td> 5</td> <td> SYR <a name="v3-EntityCode-SYR"> </a> </td> <td> Syringe</td> <td> A barrel with a plunger. <br/> </td> </tr> <tr> <td> 4</td> <td> APLCTR <a name="v3-EntityCode-APLCTR"> </a> </td> <td> Applicator</td> <td> A device used to apply a liquid or powder to a surface. <br/> </td> </tr> <tr> <td> 4</td> <td> INH <a name="v3-EntityCode-INH"> </a> </td> <td> Inhaler</td> <td> A small device used for inhaling medicine in the form of a vapour or gas in order to ease a respiratory condition such as asthma or to relieve nasal congestion. <br/> </td> </tr> <tr> <td> 5</td> <td> DSKS <a name="v3-EntityCode-DSKS"> </a> </td> <td> Diskus</td> <td> The device used to inhale the doses of medication contained in the disk form. <br/> </td> </tr> <tr> <td> 5</td> <td> DSKUNH <a name="v3-EntityCode-DSKUNH"> </a> </td> <td> Diskhaler</td> <td> The device used to inhale the doses of medication contained in the disk form. <br/> </td> </tr> <tr> <td> 5</td> <td> TRBINH <a name="v3-EntityCode-TRBINH"> </a> </td> <td> Turbuhaler</td> <td> Asthma medication delivery device. <br/> </td> </tr> <tr> <td> 4</td> <td> PMP <a name="v3-EntityCode-PMP"> </a> </td> <td> Pump</td> <td> A device that is used to raise, compress, or transfer liquids or gases and is operated by a piston or similar mechanism. <br/> </td> </tr> <tr> <td> 2</td> <td> <span style="color: grey"> <i> (_SpecimenAdditiveEntity)</i> </span> <b> <i> Abstract</i> </b> </td> <td> <a name="v3-EntityCode-_SpecimenAdditiveEntity"> </a> </td> <td> Set of codes related to specimen additives <br/> </td> </tr> <tr> <td> 3</td> <td> ACDA <a name="v3-EntityCode-ACDA"> </a> </td> <td> ACD Solution A</td> <td> ACD Solution A of trisodium citrate, 22.0g/L; citric acid, 8.0 g/L; and dextrose 24.5 g/L. Used in Blood banking and histocompatibilty testing <br/> </td> </tr> <tr> <td> 3</td> <td> ACDB <a name="v3-EntityCode-ACDB"> </a> </td> <td> ACD Solution B</td> <td> ACD Solution B of trisodium citrate, 13.2g/L; citric acid, 4.8 g/L; and dextrose 14.7 g/L. Used in Blood banking and histocompatibilty testing. <br/> </td> </tr> <tr> <td> 3</td> <td> ACET <a name="v3-EntityCode-ACET"> </a> </td> <td> Acetic Acid</td> <td> 50% V/V acetic acid in water. Used as a urine preservative <br/> </td> </tr> <tr> <td> 3</td> <td> AMIES <a name="v3-EntityCode-AMIES"> </a> </td> <td> Amies transport medium</td> <td> Sodium Chloride 3.0g, Potassium Chloride 0.2g, Calcium Chloride 0.1g, Magnesium Chloride 0.1g, Monopotassium Phosphate 0.2g, Disodium Phosphate 1.15g, Sodium Thiogly collate 1.0g, Distilled Water 1 liter <br/> </td> </tr> <tr> <td> 3</td> <td> BACTM <a name="v3-EntityCode-BACTM"> </a> </td> <td> Bacterial Transport medium</td> <td> Any medium used to maintain bacterial viability (e.g. Stuart's, Cary-Blair, Amies) <br/> </td> </tr> <tr> <td> 3</td> <td> BF10 <a name="v3-EntityCode-BF10"> </a> </td> <td> Buffered 10% formalin</td> <td> Formaldehyde 4% w/v; methyl alcohol 1% w/v; phosphate buffering salts. Tissue preservative <br/> </td> </tr> <tr> <td> 3</td> <td> BOR <a name="v3-EntityCode-BOR"> </a> </td> <td> Boric Acid</td> <td> Powdered boric acid (usually 10 g) added to 24-hour urine collections as a preservative. <br/> </td> </tr> <tr> <td> 3</td> <td> BOUIN <a name="v3-EntityCode-BOUIN"> </a> </td> <td> Bouin's solution</td> <td> Picric acid, saturated aqueous solution (750.0 ml), 37-40% formalin (250.0 ml), glacial acetic acid (50.0 ml). Tissue preservative. <br/> </td> </tr> <tr> <td> 3</td> <td> BSKM <a name="v3-EntityCode-BSKM"> </a> </td> <td> Buffered skim milk</td> <td> 50% skim milk in 0.01 M phosphate-buffered saline. Maintain virus viability <br/> </td> </tr> <tr> <td> 3</td> <td> C32 <a name="v3-EntityCode-C32"> </a> </td> <td> 3.2% Citrate</td> <td> A 3.2% solution of Sodium Citrate in water. Used as a blood preservative <br/> </td> </tr> <tr> <td> 3</td> <td> C38 <a name="v3-EntityCode-C38"> </a> </td> <td> 3.8% Citrate</td> <td> A 3.8% solution of Sodium Citrate in water. Used as a blood preservative <br/> </td> </tr> <tr> <td> 3</td> <td> CARS <a name="v3-EntityCode-CARS"> </a> </td> <td> Carson's Modified 10% formalin</td> <td> A modification of buffered 10% formalin used as a general tissue preservative. <br/> </td> </tr> <tr> <td> 3</td> <td> CARY <a name="v3-EntityCode-CARY"> </a> </td> <td> Cary Blair Medium</td> <td> Sodium Thioglycollate 1.5 g, Disodium Hydrogen Phosphate 1.1 g, Sodium Chloride 5.0 g, Calcium Chloride 0.09 g, Agar 5.0 g, per Liter of Water <br/> </td> </tr> <tr> <td> 3</td> <td> CHLTM <a name="v3-EntityCode-CHLTM"> </a> </td> <td> Chlamydia transport medium</td> <td> Any of a number of non-nutritive buffered media used to maintain Chlamydia viability during transportation to the laboratory <br/> </td> </tr> <tr> <td> 3</td> <td> CTAD <a name="v3-EntityCode-CTAD"> </a> </td> <td> CTAD</td> <td> Buffered tri-sodium citrate solution with theophylline, adenosine and dipyridamole <br/> </td> </tr> <tr> <td> 3</td> <td> EDTK15 <a name="v3-EntityCode-EDTK15"> </a> </td> <td> Potassium/K EDTA 15%</td> <td> Potassium EDTA 15% solution in water <br/> </td> </tr> <tr> <td> 3</td> <td> EDTK75 <a name="v3-EntityCode-EDTK75"> </a> </td> <td> Potassium/K EDTA 7.5%</td> <td> Potassium EDTA 7.5% solution in water <br/> </td> </tr> <tr> <td> 3</td> <td> EDTN <a name="v3-EntityCode-EDTN"> </a> </td> <td> Sodium/Na EDTA</td> <td> Sodium fluoride and Disodium EDTA <br/> </td> </tr> <tr> <td> 3</td> <td> ENT <a name="v3-EntityCode-ENT"> </a> </td> <td> Enteric bacteria transport medium</td> <td> Any of a number of non-nutritive buffered media used to maintain enteric bacterial viability during transportation to the laboratory <br/> </td> </tr> <tr> <td> 3</td> <td> F10 <a name="v3-EntityCode-F10"> </a> </td> <td> 10% Formalin</td> <td> A 10% v/v solution in water of formalin( a 37% solution of formaldehyde and water). Used for tissue preservation. <br/> </td> </tr> <tr> <td> 3</td> <td> FDP <a name="v3-EntityCode-FDP"> </a> </td> <td> Thrombin NIH; soybean trypsin inhibitor</td> <td> Thrombin plus soybean trypsin inhibitor. For use in identifying fibrn degredation products. <br/> </td> </tr> <tr> <td> 3</td> <td> FL10 <a name="v3-EntityCode-FL10"> </a> </td> <td> Sodium Fluoride, 10mg</td> <td> Sodium fluoride, 10mg added as a urine preservative. <br/> </td> </tr> <tr> <td> 3</td> <td> FL100 <a name="v3-EntityCode-FL100"> </a> </td> <td> Sodium Fluoride, 100mg</td> <td> Sodium fluoride, 100mg added as a urine preservative. <br/> </td> </tr> <tr> <td> 3</td> <td> HCL6 <a name="v3-EntityCode-HCL6"> </a> </td> <td> 6N HCL</td> <td> A solution of HCl containing 6moles of hydrogen ion/L. Used as a Urine Preservative. <br/> </td> </tr> <tr> <td> 3</td> <td> HEPA <a name="v3-EntityCode-HEPA"> </a> </td> <td> Ammonium heparin</td> <td> Ammonium heparin <br/> </td> </tr> <tr> <td> 3</td> <td> HEPL <a name="v3-EntityCode-HEPL"> </a> </td> <td> Lithium/Li Heparin</td> <td> Lithium heparin salt <br/> </td> </tr> <tr> <td> 3</td> <td> HEPN <a name="v3-EntityCode-HEPN"> </a> </td> <td> Sodium/Na Heparin</td> <td> Sodium heparin salt <br/> </td> </tr> <tr> <td> 3</td> <td> HNO3 <a name="v3-EntityCode-HNO3"> </a> </td> <td> Nitric Acid</td> <td> 6N Nitric acid used to preserve urine for heavy metal analysis. <br/> </td> </tr> <tr> <td> 3</td> <td> JKM <a name="v3-EntityCode-JKM"> </a> </td> <td> Jones Kendrick Medium</td> <td> A transport medium formulated to maintain Bordetella pertussis viability. <br/> </td> </tr> <tr> <td> 3</td> <td> KARN <a name="v3-EntityCode-KARN"> </a> </td> <td> Karnovsky's fixative</td> <td> 5% Glutaraldehyde, 4% Formaldehyde in 0.08M buffer. Tissue preservation <br/> </td> </tr> <tr> <td> 3</td> <td> KOX <a name="v3-EntityCode-KOX"> </a> </td> <td> Potassium Oxalate</td> <td> Potassium oxalate and sodium fluoride in a 1.25:1 ratio <br/> </td> </tr> <tr> <td> 3</td> <td> LIA <a name="v3-EntityCode-LIA"> </a> </td> <td> Lithium iodoacetate</td> <td> Iodoacetate lithium salt <br/> </td> </tr> <tr> <td> 3</td> <td> M4 <a name="v3-EntityCode-M4"> </a> </td> <td> M4</td> <td> Modified Hank's balanced salt solution supplemented with bovine serum albumin, gelatin, sucrose and glutamic acid. It is buffered to pH 7.3+ or - 0.2 with HEPES buffer. Phenol red is used to indicate pH. Vancomycin, Amphotericin B and Colistin are used to <br/> </td> </tr> <tr> <td> 3</td> <td> M4RT <a name="v3-EntityCode-M4RT"> </a> </td> <td> M4-RT</td> <td> Modified Hank's balanced salt solution supplemented with bovine serum albumin, gelatin, sucrose and glutamic acid. It is buffered to pH 7.3+ or - 0.2 with Hepes buffer. Phenol red is used to indicate pH. Gentamicin and amphotericin B are used to inhibit c <br/> </td> </tr> <tr> <td> 3</td> <td> M5 <a name="v3-EntityCode-M5"> </a> </td> <td> M5</td> <td> Modified Hank's balanced salt solution supplemented with protein stabilizers, sucrose and glutamic acid. It is buffered to pH 7.3+ or - 0.2 with Hepes buffer. Phenol red is used to indicate pH. Vancomycin, Amphotericin B and Colistin are used to inhibit c <br/> </td> </tr> <tr> <td> 3</td> <td> MICHTM <a name="v3-EntityCode-MICHTM"> </a> </td> <td> Michel's transport medium</td> <td> 1M potassium citrate, pH 7.0 2.5 ml, 0.1M magnesium sulfate 5.0 ml, 0.1M N-ethyl malemide 5.0 ml, dH2O 87.5 ml, ammonium sulfate 55gm. Preserve antigens for Immunofluorescence procedures <br/> </td> </tr> <tr> <td> 3</td> <td> MMDTM <a name="v3-EntityCode-MMDTM"> </a> </td> <td> MMD transport medium</td> <td> A buffered medium with ammonium sulfate added to preserve antigens for Immunofluorescence procedures <br/> </td> </tr> <tr> <td> 3</td> <td> NAF <a name="v3-EntityCode-NAF"> </a> </td> <td> Sodium Fluoride</td> <td> Sodium fluoride <br/> </td> </tr> <tr> <td> 3</td> <td> NONE <a name="v3-EntityCode-NONE"> </a> </td> <td> None</td> <td> No additive. Specifically identifes the specimen as having no additives. <br/> </td> </tr> <tr> <td> 3</td> <td> PAGE <a name="v3-EntityCode-PAGE"> </a> </td> <td> Page's Saline</td> <td> 0.12 g NaCl, 0.004 g MgSO, 0.004 g, CaCl, 0.142 g Na2HPO4 and 0.136 g KH2PO4 per liter of distilled water. Maintain Acanthaoemba viability. <br/> </td> </tr> <tr> <td> 3</td> <td> PHENOL <a name="v3-EntityCode-PHENOL"> </a> </td> <td> Phenol</td> <td> Phenol. Urine preservative <br/> </td> </tr> <tr> <td> 3</td> <td> PVA <a name="v3-EntityCode-PVA"> </a> </td> <td> Polyvinylalcohol</td> <td> Polyvinyl alcohol <br/> </td> </tr> <tr> <td> 3</td> <td> RLM <a name="v3-EntityCode-RLM"> </a> </td> <td> Reagan Lowe Medium</td> <td> A transport medium formulated to maintain Bordetella pertussis viability. <br/> </td> </tr> <tr> <td> 3</td> <td> SILICA <a name="v3-EntityCode-SILICA"> </a> </td> <td> Siliceous earth</td> <td> Diatomaceous earth. For glucose determination blood samples <br/> </td> </tr> <tr> <td> 3</td> <td> SPS <a name="v3-EntityCode-SPS"> </a> </td> <td> Sodium polyanethol sulfonate 0.35% in 0.85% sodium chloride</td> <td> Sodium polyanethol sulfonate in saline. Anticomplementary and antiphagocytic properties. Used in blood culture collection. <br/> </td> </tr> <tr> <td> 3</td> <td> SST <a name="v3-EntityCode-SST"> </a> </td> <td> Serum Separator Tube</td> <td> Polymer separator gel with clot activator <br/> </td> </tr> <tr> <td> 3</td> <td> STUTM <a name="v3-EntityCode-STUTM"> </a> </td> <td> Stuart transport medium</td> <td> Sodium Glycerophosphate 10.0g, Calcium Chloride 0.1g, Mercaptoacetic Acid 1.0ml, Distilled Water 1 liter <br/> </td> </tr> <tr> <td> 3</td> <td> THROM <a name="v3-EntityCode-THROM"> </a> </td> <td> Thrombin</td> <td> Thrombin. Accelerates clotting. <br/> </td> </tr> <tr> <td> 3</td> <td> THYMOL <a name="v3-EntityCode-THYMOL"> </a> </td> <td> Thymol</td> <td> 2-Isopropyl-5-methyl phenol. A preservative for 24 Hr Urine samples <br/> </td> </tr> <tr> <td> 3</td> <td> THYO <a name="v3-EntityCode-THYO"> </a> </td> <td> Thyoglycolate broth</td> <td> A nutritive medium with a reducing agent (sodium thioglycolate) which, due to a chemical reaction, removes oxygen from the broth. <br/> </td> </tr> <tr> <td> 3</td> <td> TOLU <a name="v3-EntityCode-TOLU"> </a> </td> <td> Toluene</td> <td> Also known as Methylbenzene; Toluol; Phenylmethane. A preservative for 24 Hr Urine samples <br/> </td> </tr> <tr> <td> 3</td> <td> URETM <a name="v3-EntityCode-URETM"> </a> </td> <td> Ureaplasma transport medium</td> <td> A buffered salt solution with antifungal agents added for the collection and transport of Ureaplasma specimens. <br/> </td> </tr> <tr> <td> 3</td> <td> VIRTM <a name="v3-EntityCode-VIRTM"> </a> </td> <td> Viral Transport medium</td> <td> Sucrose 74.6g, Potassium hydrogenphosphate 0.52g, L-glutamic acid 0.72g, Bovine serum albumin 5.0g, Gentamicin 50mg, Potassium dihydrogenphosphate 1.25g, L-15 medium 9.9L, Water to 10L. Maintain Virus viability. <br/> </td> </tr> <tr> <td> 3</td> <td> WEST <a name="v3-EntityCode-WEST"> </a> </td> <td> Buffered Citrate</td> <td> 3.8% Citrate buffered to a pH of 5.5 for Westergren Sedimentation Rate <br/> </td> </tr> <tr> <td> 2</td> <td> BLDPRD <a name="v3-EntityCode-BLDPRD"> </a> </td> <td> Blood Product</td> <td> A manufactured product that is produced from the raw blood oi a donor with the intention of using it in a recipient transfusion. <br/> </td> </tr> <tr> <td> 2</td> <td> VCCNE <a name="v3-EntityCode-VCCNE"> </a> </td> <td> Vaccine</td> <td> A Type of medicine that creates an immune protection without the recipient experiencing the disease. <br/> </td> </tr> <tr> <td> 2</td> <td> <span style="color: grey"> <i> (_DrugEntity)</i> </span> <b> <i> Abstract</i> </b> </td> <td> <a name="v3-EntityCode-_DrugEntity"> </a> </td> <td> A substance whose therapeutic effect is produced by chemical action within the body. <br/> </td> </tr> <tr> <td> 3</td> <td> <span style="color: grey"> <i> (_ClinicalDrug)</i> </span> <b> <i> Abstract</i> </b> </td> <td> <a name="v3-EntityCode-_ClinicalDrug"> </a> </td> <td> Any substance or mixture of substances manufactured, sold or represented for use in: (a) the diagnosis, treatment, mitigation or prevention of a disease, disorder, abnormal physical state, or its symptoms, in human beings or animals; (b) restoring, correcting or modifying organic functions in human beings or animals. <br/> </td> </tr> <tr> <td> 1</td> <td> <span style="color: grey"> <i> (_NonDrugAgentEntity)</i> </span> <b> <i> Abstract</i> </b> </td> <td> <a name="v3-EntityCode-_NonDrugAgentEntity"> </a> </td> <td> Indicates types of allergy and intolerance agents which are non-drugs. (E.g. foods, latex, etc.) <br/> </td> </tr> <tr> <td> 2</td> <td> NDA01 <a name="v3-EntityCode-NDA01"> </a> </td> <td> egg</td> <td/> </tr> <tr> <td> 2</td> <td> NDA02 <a name="v3-EntityCode-NDA02"> </a> </td> <td> fish</td> <td/> </tr> <tr> <td> 2</td> <td> NDA03 <a name="v3-EntityCode-NDA03"> </a> </td> <td> lactose</td> <td/> </tr> <tr> <td> 2</td> <td> NDA04 <a name="v3-EntityCode-NDA04"> </a> </td> <td> peanut</td> <td/> </tr> <tr> <td> 2</td> <td> NDA05 <a name="v3-EntityCode-NDA05"> </a> </td> <td> soy</td> <td/> </tr> <tr> <td> 2</td> <td> NDA06 <a name="v3-EntityCode-NDA06"> </a> </td> <td> sulfites</td> <td/> </tr> <tr> <td> 2</td> <td> NDA07 <a name="v3-EntityCode-NDA07"> </a> </td> <td> wheat or gluten</td> <td/> </tr> <tr> <td> 2</td> <td> NDA08 <a name="v3-EntityCode-NDA08"> </a> </td> <td> isocyanates</td> <td/> </tr> <tr> <td> 2</td> <td> NDA09 <a name="v3-EntityCode-NDA09"> </a> </td> <td> solvents</td> <td/> </tr> <tr> <td> 2</td> <td> NDA10 <a name="v3-EntityCode-NDA10"> </a> </td> <td> oils</td> <td/> </tr> <tr> <td> 2</td> <td> NDA11 <a name="v3-EntityCode-NDA11"> </a> </td> <td> venoms</td> <td/> </tr> <tr> <td> 2</td> <td> NDA12 <a name="v3-EntityCode-NDA12"> </a> </td> <td> latex</td> <td/> </tr> <tr> <td> 2</td> <td> NDA13 <a name="v3-EntityCode-NDA13"> </a> </td> <td> shellfish</td> <td/> </tr> <tr> <td> 2</td> <td> NDA14 <a name="v3-EntityCode-NDA14"> </a> </td> <td> strawberries</td> <td/> </tr> <tr> <td> 2</td> <td> NDA15 <a name="v3-EntityCode-NDA15"> </a> </td> <td> tomatoes</td> <td/> </tr> <tr> <td> 2</td> <td> NDA16 <a name="v3-EntityCode-NDA16"> </a> </td> <td> dust</td> <td/> </tr> <tr> <td> 2</td> <td> NDA17 <a name="v3-EntityCode-NDA17"> </a> </td> <td> dust mites</td> <td/> </tr> <tr> <td> 1</td> <td> <span style="color: grey"> <i> (_OrganizationEntityType)</i> </span> <b> <i> Abstract</i> </b> </td> <td> <a name="v3-EntityCode-_OrganizationEntityType"> </a> </td> <td> Further classifies entities of classCode ORG. <br/> </td> </tr> <tr> <td> 2</td> <td> HHOLD <a name="v3-EntityCode-HHOLD"> </a> </td> <td> household</td> <td> The group of persons who occupy a single housing unit. <br/> </td> </tr> <tr> <td> 2</td> <td> NAT <a name="v3-EntityCode-NAT"> </a> </td> <td> NationEntityType</td> <td> Codes identifying nation states. Allows for finer grained specification of Entity with classcode <= NAT <br/> Example:ISO3166 country codes. <br/> </td> </tr> <tr> <td> 2</td> <td> RELIG <a name="v3-EntityCode-RELIG"> </a> </td> <td> religious institution</td> <td> An organization that provides religious rites of worship. <br/> </td> </tr> <tr> <td> 1</td> <td> <span style="color: grey"> <i> (_PlaceEntityType)</i> </span> <b> <i> Abstract</i> </b> </td> <td> <a name="v3-EntityCode-_PlaceEntityType"> </a> </td> <td> Types of places for EntityClass "PLC" <br/> </td> </tr> <tr> <td> 2</td> <td> BED <a name="v3-EntityCode-BED"> </a> </td> <td> Bed Location</td> <td> The location of a bed <br/> </td> </tr> <tr> <td> 2</td> <td> BLDG <a name="v3-EntityCode-BLDG"> </a> </td> <td> Building Location</td> <td> The location of a building <br/> </td> </tr> <tr> <td> 2</td> <td> FLOOR <a name="v3-EntityCode-FLOOR"> </a> </td> <td> Floor Location</td> <td> The location of a floor of a building <br/> </td> </tr> <tr> <td> 2</td> <td> ROOM <a name="v3-EntityCode-ROOM"> </a> </td> <td> Room Location</td> <td> The location of a room <br/> </td> </tr> <tr> <td> 2</td> <td> WING <a name="v3-EntityCode-WING"> </a> </td> <td> Wing Location</td> <td> The location of a wing of a building (e.g. East Wing). The same room number for the same floor number can be distinguished by wing number in some situations <br/> </td> </tr> <tr> <td> 1</td> <td> <span style="color: grey"> <i> (_ResourceGroupEntityType)</i> </span> <b> <i> Abstract</i> </b> </td> <td> <a name="v3-EntityCode-_ResourceGroupEntityType"> </a> </td> <td> Codes to characterize a Resource Group using categories that typify its membership and/or function <br/> . <br/> Example: PractitionerGroup <br/> </td> </tr> <tr> <td> 2</td> <td> PRAC <a name="v3-EntityCode-PRAC"> </a> </td> <td> PractitionerGroup</td> <td/> </tr> </table> </div> </text> <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-ballot-status"> <valueString value="External"/> </extension> <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm"> <valueInteger value="0"/> </extension> <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-wg"> <valueString value="vocab"/> </extension> <url value="http://hl7.org/fhir/ValueSet/v3-EntityCode"/> <version value="2017-07-31"/> <name value="v3 Code System EntityCode"/> <status value="active"/> <experimental value="false"/> <date value="2017-07-31"/> <publisher value="HL7, Inc"/> <contact> <telecom> <system value="url"/> <value value="http://hl7.org"/> </telecom> </contact> <description value=" OpenIssue: Missing description."/> <immutable value="true"/> <compose> <include> <system value="http://hl7.org/fhir/v3/EntityCode"/> </include> </compose> </ValueSet>
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.
®© HL7.org 2011+. FHIR Release 4 Draft for Comment (Jan-2018 v3.2.0-12885) generated on Wed, Dec 20, 2017 15:59+1100. QA Page
Links: Search |
Version History |
Table of Contents |
Credits |
Compare to DSTU3 |
|
Propose a change